MHRA Threat to clinics In communication with the MHRA, they also stated: However, we do have concerns about the level of clinical oversight present in IV vitamin therapy and injection services in general and the appropriacy of such services is currently under review. This review, if deciding on stopping treatment of B12 injections by clinics who do comply with the ridiculous rules of the MHRA, would not only negatively impact the companies and individuals who give B12 injections, but also to the people who rely on them to keep functioning both physically and mentally
BPC-157 acts primarily at the tissue and gut level - more localised, faster-acting on specific injury sites and gut lining
Some studies say long-term use can lower B12 levels
However, glucose monitoring is essential, as GH can induce insulin resistance while GLP-1s enhance insulin sensitivity
After that initial period, it is common to continue injections monthly, though less frequent intervals might be OK if cobalamin blood levels are supportive
It produces the most consistent results, allows precise dose titration, and matches the route used in nearly all preclinical research